1. Market Research
  2. > Pharmaceutical
  3. > Generic Drug Market Trends
GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

  • April 2018
  • 88 pages
  • ID: 5083195
  • Format: PDF
  • By International Market Analysis Research and Consult

Summary

Table of Contents

Generic drugs are low-cost versions of off-patent innovator drugs with the same dosage, effects, use, route of administration, etc.

In the GCC region, the demand for generic drugs has been rising due to the cost-containment measure by the governments stimulated by the unsustainably high spending on healthcare in the region. A large expatriate and low-income population also acts as a driver for the market growth. According to IMARC Group’s latest report titled “GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the generic drugs market in the GCC reached a value of nearly US$ 1,783 Million in 2017, exhibiting a CAGR of 15% during 2010-2017.

One of the major factors that is expected to boost the market is the mounting pharmaceutical manufacturing capacity in the region boosted by the plans for regional integration and a greater emphasis on drugs produced within the GCC. The efforts to reduce dependence on imported drugs will further stimulate domestic manufacturing of drugs, particularly generics. Moreover, the government of Saudi Arabia, Oman and UAE have started campaigns aimed at boosting awareness towards the substitution of branded drugs by generics. However, the preference for branded drugs supported by a significant affluent population and the demand for sophisticated pharmaceuticals can hamper the market growth. Overall, the market is expected to continue its growth, reaching a value of more than US$ XXXX Million by 2023.

The report has segmented the GCC generic drugs market on the basis of countries. Currently, Saudi Arabia represents the largest market in the region, accounting for more than a half of the total market share. This can be attributed to the rapid economic development and the subsequent rise in the cases of lifestyles diseases in the country. The lenient data exclusivity laws in the country have also boosted the market. The report has further analysed the competitive landscape of the market and provides the profiles of the key players operating in it. Some of the key players include SPIMACO, Pfizer, Novartis, TPMC and Hikma.

This report provides a deep insight into the GCC generic drug industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic drugs manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the GCC generic drugs industry in any manner.

Key Questions Answered in This Report:
How has the GCC generic drugs market performed so far and how will it perform in the coming years?
What are the key regional markets in the GCC generic drugs industry?
What are the price trends of generic drugs?
What are the various stages in the value chain of the GCC generic drugs industry?
What are the key driving factors and challenges in the GCC generic drugs industry?
What is the structure of the GCC generic drugs industry and who are the key players?
What is the degree of competition in the GCC generic drugs industry?
What are the profit margins in the GCC generic drugs industry?
What are the key requirements for setting up a generic drugs manufacturing plant?
How are generic drugs manufactured?
What are the various unit operations involved in a generic drugs manufacturing plant?
What is the total size of land required for setting up a generic drugs manufacturing plant?
What are the machinery requirements for setting up a generic drugs manufacturing plant?
What are the raw material requirements for setting up a generic drugs manufacturing plant?
What are the packaging requirements for generic drugs?
What are the transportation requirements for generic drugs?
What are the utility requirements for setting up a generic drugs manufacturing plant?
What are the manpower requirements for setting up a generic drugs manufacturing plant?
What are the infrastructure costs for setting up a generic drugs manufacturing plant?
What are the capital costs for setting up a generic drugs manufacturing plant?
What are the operating costs for setting up a generic drugs manufacturing plant?
What will be the income and expenditures for a generic drugs manufacturing plant?
What is the time required to break-even?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Generic Drugs Markets in China

Generic Drugs Markets in China

  • $ 4000
  • October 2019

China’s demand for Generic Drugs has grown at a fast pace in the past decade.In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which ...

Generic Drugs: Leading Companies Capabilities, Goals and Strategies

Generic Drugs: Leading Companies Capabilities, Goals and Strategies

  • $ 3500
  • August 2019

Generic Drugs: Leading Companies Capabilities, Goals and StrategiesThis report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market ...

Generic Drugs Industry Forecasts - China Focus

Generic Drugs Industry Forecasts - China Focus

  • $ 1800
  • October 2019

This study focuses on China’s Generic Drugs industry forecasts.In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising ...

Generic Drugs Companies in China $ 1800 October 2019

Consumer Health in Uruguay $ 2650 October 2019


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on